Establishment of non-invasive model for prediction renal fibrosis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052461

Enrollment

Unknown

Registered

2021-10-27

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Gold Standard:Pathology via renal biopsy.

Index test:serum&#32

LOX,lncRNA-GAS5,serum&#32

creatinine index&#32

of&#32

untrasound&#32

and&#32

MRI

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Chronic renal structural and functional disorders due to various causes (history of kidney damage > 3 months), including normal and abnormal pathological lesions of renal GFR, abnormal blood or urine composition, and imaging abnormalities, or unexplained decline of GFR (<60ml/min/1.73m2) over 3 months.

Exclusion criteria

Exclusion criteria: 1.Aged 80; 2.There are contraindications for renal biopsy; 3.Acute renal injury.

Design outcomes

Primary

Measure	Time frame
lysine oxidase;lncRNA-GAS5;creatinine;	—

Countries

China

Contacts

Public ContactZhang Yingying

Shanghai Tongji Hospital

idklaa@126.com+86 13761287274

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026